Cambridge Healthcare Research, a life sciences and healthcare consultancy, has named Chris Stevenson as its new director, it was reported yesterday.
The new director was a former Johnson and Johnson, Cello Health and Thompson Reuters president. He is now working at global strategic marketing consultancy, Osprey Health Consulting, and has more than 30 years' experience in the pharmaceutical and professional services industry.
Stevenson's appointment is part of Cambridge's effort to scale, and increase the value of its offerings to present and new clients in product strategy, commercialisation and in competitor analysis.
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Enable Biosciences names new chief financial officer
Cadenza Bio names new director
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation